Healthcare -
Biotechnology - NASDAQ - US
$ 54.8
-1.03 %
$ 6.97 B
Market Cap
18.15
P/E
HALO - INTEREST INCOME & EXPENSE
Interest Income & Expense HALO - Halozyme Therapeutics, Inc.
18.8 M
LAST VALUE
57.89%
2 YEAR CAGR
0.79%
5 YEAR CAGR
19.07%
10 YEAR CAGR